<DOC>
	<DOCNO>NCT00057746</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know radiation therapy regimen effective prevent brain metastasis patient limited-stage small cell lung cancer take account chronic neurotoxicity radiation therapy . PURPOSE : This randomized phase II trial compare incidence chronic neurotoxicity three different brain irradiation regimen . The corresponding phase III component address prevention brain metastasis run EORTC report separately ( NCT00005062 ) .</brief_summary>
	<brief_title>Brain Irradiation Treating Patients With Limited-Stage Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare incidence chronic neurotoxicity patient treat regimen . - Compare quality life patient treat regimen . ( phase III close accrual 12/31/05 ) OUTLINE : This randomize , multicenter study . Patients stratify accord age ( 60 vs 60 ) time since induction therapy ( 90 day less vs 91-180 day v 181-240 day ) . Patients randomize 1 3 treatment arm . - Arm I : Patients undergo prophylactic cranial irradiation ( PCI ) daily 5 day week . Treatment continue 2 week absence unacceptable toxicity . - Arm II : Patients undergo PCI daily 5 day week . Treatment continue 2.6 week absence unacceptable toxicity . - Arm III : Patients undergo PCI twice daily 5 day week . Treatment continue 3.4 week absence unacceptable toxicity . Quality life assess baseline , every 6 month 1 year , annually 3 year . Patients follow every 6 month 1 year annually 3 year . PROJECTED ACCRUAL : A total 264 patient accrue study within 3.5 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm small cell lung cancer fine needle aspiration , biopsy , 2 positive sputum Limited stage ( IIIIB ) Confined 1 hemithorax No T4 base malignant pleural effusion , N3 disease base contralateral hilar contralateral supraclavicular involvement Complete response induction chemotherapy ( without thoracic radiotherapy ) Consolidative chest radiotherapy may initiate study No radiographic evidence following : Brain metastasis Normal brain CT scan MRI le 1 month study Ipsilateral lung metastasis Malignant pleural effusion Minimal pleural effusion chest CT scan allow , chest xray PATIENT CHARACTERISTICS : Age Not specify Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Absolute granulocyte count least 1,500/mm^3 Platelet count least 75,000/mm^3 Hemoglobin least 10.0 g/dL^ Hepatic Not specify Renal Not specify Pulmonary See Disease Characteristics Other Not pregnant nursing Fertile patient must use effective contraception Neurological function class 1 2 No epilepsy require permanent oral medication No malignancy within past 5 year except nonmelanoma skin cancer carcinoma situ cervix No serious medical psychiatric condition would preclude study participation PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics At least 1 week since prior chemotherapy No concurrent chemotherapy Endocrine therapy Not specify Radiotherapy See Disease Characteristics No prior external beam radiotherapy head neck , include stereotactic radiotherapy Concurrent thoracic radiotherapy allow Surgery Not specify Other No concurrent antitumor agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>limited stage small cell lung cancer</keyword>
</DOC>